Skip to main content
letter
. 2010 Aug 16;54(11):4948–4949. doi: 10.1128/AAC.00415-10

TABLE 1.

Frequency of mutants of P. aeruginosa PA14 and its hypermutable mutS derivative resistant to single antibiotics and their combinations with fosfomycin

Antibiotic(s) MICa (μg/ml) Concnb (μg/ml) Mutant frequency
WT mutS
Fosfomycin 8 128 2.3 × 10−6 2.1 × 10−4
Tobramycin 1 4 2.2 × 10−9 1.4 × 10−7
Amikacin 1 16 2.6 × 10−9 1.2 × 10−7
Imipenem 0.5 8 1.5 × 10−7 1.6 × 10−5
Meropenem 0.25 8 4.2 × 10−8 1.3 × 10−6
Ceftazidime 1 8 1.3 × 10−8 1.3 × 10−6
Ciprofloxacin 0.1 1 1.1 × 10−9 9.0 × 10−7
Colistin 0.5 2 <1.0 × 10−10 <1.0 × 10−10
Tobramycin + fosfomycin 4 + 128 <1.0 × 10−10 <1.0 × 10−10
Amikacin + fosfomycin 16 + 128 <1.0 × 10−10 <1.0 × 10−10
Imipenem + fosfomycin 8 + 128 1.1 × 10−9 1.1 × 10−7
Meropenem + fosfomycin 8 + 128 <1.0 × 10−10 <1.0 × 10−10
Ceftazidime + fosfomycin 8 + 128 <1.0 × 10−10 1.0 × 10−8
Ciprofloxacin + fosfomycin 1 + 128 <1.0 × 10−10 <1.0 × 10−10
Colistin + fosfomycin 2 + 128 <1.0 × 10−10 <1.0 × 10−10
a

The MICs for PA14 (WT) and its mutS derivative were identical in all cases. For all antibiotics, the MIC was determined as recommended by the CLSI (1).

b

Final concentration used for calculation of mutant frequency.